Azelaprag
N/A
Report date: 2025/02/26 20:00:45
NME
Base Information
Drug NameAzelaprag
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A
Develop Information
Active CompaniesBioAge Labs Inc
Inactive CompaniesEli Lilly And CompanyAmgen Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A